Table 1.
Prevalence of overall H. pylori (HP) infection (%) and CagA status (%) in autoimmune thyroid diseases (AITDs) patients and controls. HP+, infected individuals; CagA+ or CagA−, infected individuals with or without anti-CagA antibodies; GD, Grave’s disease; HT, Hashimoto’s thyroiditis; AT, aspecific thyroiditis.
| H. pylori/CagA Status | GD (%) | HT (%) | AT (%) | Controls (%) |
|---|---|---|---|---|
| HP+ | 26 (66.6) | 49 (64.4) | 15 (34.0) | 40 (29.4) |
| HP− | 13 (33.3) | 27 (35.5) | 29 (65.9) | 96 (70.5) |
| Total | 39 | 76 | 44 | 136 |
| HP+/CagA+ | 12 (46.1) | 23 (46.9) | 7 (46.6) | 8 (20.0) |
| HP+/CagA− | 14 (53.8) | 26 (53.0) | 8 (53.3) | 32 (80.0) |